Several areas across the University, including CTSI, recently came together to provide funding and project support for three University researchers and their microbiome analysis technology—to get it out of the lab and into the marketplace so that it can improve human health.
CTSI and the Pediatric Device Innovation Consortium award four University of Minnesota research projects with funding and project support to develop pediatric medical devices.
Four research teams have been awarded up to $50,000 each to pursue health research projects that have the potential to lead to a start-up company or license agreement. If successful, the University of Minnesota and Mayo Clinic grantees will be eligible to apply for up to $400,000 in additional funding.
The third annual Pediatric Device Breakthrough Collaborative united individuals from a wide range of organizations around a shared goal of accelerating the development of medical devices for kids.
One way CTSI and The Pediatric Device Innovation Consortium (PDIC) have teamed up to advance rare disease research is by supporting the efforts of Dr. Kyriakie Sarafoglou, as she explores better ways to help children with adrenal insufficiency.
Kids with this rare condition lack intrinsic steroid production, so simple childhood illnesses can cause them to get very sick and even become life-threatening.
There’s a new funding opportunity for University of Minnesota researchers developing diagnostics and treatments for rare diseases, thanks to the recent release of an RFA from CTSI’s Translational Grant Program. CTSI anticipates funding up to two projects, with each project receiving as much as $50,000 in direct costs for one year.
“The Committee for Pharmaceutical Development infused new life into our treatment idea, and propelled it toward clinical trials. We would not be where we’re at now without its support.”
- U of M Professor Greg Beilman, MD, referring to a treatment that could help people survive severe blood loss
CTSI has released a new RFA for the Translational Product Development Fund, which supports projects that have the potential to be commercialized, such as projects that may lead to the formation of a start-up company or execution of a license agreement with an established commercial entity.
CTSI’s Office of Discovery and Translation (ODAT) recently hired Angela Fralish for the newly created ODAT Research Fellow position.
As a fellow, Angela will assess the translational potential of technologies under consideration for ODAT support or currently supported through one of six ODAT funding programs
University of Minnesota biomedical engineers showed artificial blood vessels implanted in young lambs could grow within the new owner, potentially preventing the need for repeated surgeries in children with congenital heart defects.
- Academic Health Center / Health Sciences (37)
- Accelerating discoveries (55)
- Advancing child health discoveries (27)
- Biomedical informatics (22)
- Biostatistical support (15)
- BLS (BioNet) (7)
- BMIP (25)
- BPIC (12)
- CEARCH (66)
- Clinical data repository (12)
- Clinical research professional (10)
- Clinical research services (45)
- Clinical trial management system / OnCore (10)
- Clinical trials (26)
- Community engagement in research (74)
- Community Engagement Studio (2)
- Community Research Institute (1)
- CTR Portal (5)
- CTRS (34)
- CTSA consortium (17)
- CTSI event (32)
- CTSI-Ed (90)
- Early-stage research (39)
- Fairview Research Administration (11)
- Grant (81)
- i2b2 (5)
- Interdisciplinary research (10)
- M Health (6)
- MARCH (1)
- Multisite research (14)
- NCATS (23)
- NIH (26)
- ODAT (47)
- Participate in a study (9)
- PCORI (3)
- Pilot funding (38)
- REDCap (6)
- Regulatory support (10)
- Research career & workforce development (91)
- Research mentor (43)
- Research participant recruitment (15)
- Research Toolkit (3)
- Research tools (38)
- ResearchMatch (2)
- RFA (30)
- Specimen procurement (6)
- StudyFinder (10)
- Team Science (39)
- University of Minnesota (163)